Advarra

02/01/2023

Join us in celebrating the trailblazers of clinical research this 🎉 Advarra is excited to shine a light on the impactful contributions of key historical figures who have shaped our field. Today we are starting off with a tribute to Dr. Rebecca Lee Crumpler. Stay tuned as we pay tribute to these pioneers.

01/24/2023

We're dedicated to serving the clinical research community at Advarra, and that means staying on top of the latest trends. Our new eBook, "2023 Trends Impacting Clinical Research," is a valuable resource that can help you stay informed and adapt to the changes in the industry.

https://bit.ly/3RbN09J

01/17/2023

Join us 1/26 for a webinar on the latest trends in regulatory and development challenges for rare/orphan diseases. Learn successful strategies for a proactive approach to gaining a rare/orphan disease designation and identify critical issues and steps to resolve them to achieve regulatory and development milestones. CE credits available. Register now!

https://info.advarra.com/trending-now-wbnr.html?utm_medium=social-media&utm_source=facebook&utm_campaign=trending-now-wbnr&utm_content=trending-now-wbnr

Explore the latest trends in regulatory and development challenges for rare/orphan diseases.

01/13/2023

If you’re not already using a single IRB (sIRB) for cooperative and multisite clinical trials, you probably will be soon. Relying on an sIRB can be challenging for institutions used to doing everything locally. Even those more familiar with sIRB reliance may still find it’s not as efficient or straightforward as promised. https://bit.ly/3CHFjlJ

Find out how other institutions have used sIRB requirements as an opportunity to elevate their research programs.

11/10/2022

An investigator-initiated trial (IIT) occurs when an investigator creates the idea for a study, develops the protocol, and serves as the sponsor and investigator for the trial. While this isn’t uncommon, careful planning is required in order for these trials to be successfully compliant.

Download our latest eBook: https://bit.ly/3EoEVdc

07/12/2022

This case study outlines how a biopharmaceutical company partnered with Advarra to execute a phased approach to identify opportunities for improvement, analyze their current pharmacovigilance system state, and implement R&D industry best practices for regulatory compliance.

Learn how an organization achieved organization-wide compliance and managed its post-authorization safety studies

07/11/2022

Is your IRB prepared to review protocols involving mHealth and virtual trial apps?

What questions should you ask the sponsor or researcher about these technologies?

How can researchers at your institution better plan their protocols and documentation to aide IRB review?

Explore the current regulatory landscape governing mHealth and virtual trial applications.